Dow down 0.00% Nasdaq down 0.31%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow down 0.00% Nasdaq down 0.31%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
10:51am EST 167.755 +0.935 +0.56% 165.67 168.16 248,032 1,282,400 24.543B Sparkline Chart Chart, News, Stats, Options, Board
10:51am EST 4.10 +0.65 +18.84% 3.95 4.45 3,079,746 212,216 97.25M Sparkline Chart Chart, News, Stats, Board
10:52am EST 158.82 +0.34 +0.21% 157.66 158.98 223,435 1,918,030 62.74B Sparkline Chart Chart, News, Stats, Options, Board
{"s" : "ilmn,life,tmo","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

Quotes delayed, except where indicated otherwise.

Recent News

day and time symbols news headline and source
OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day GlobeNewswire09:30am EST
Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing Program Business Wire09:00am EST
3 Top Healthcare Stocks to Buy Now at Motley Fool08:01am EST
8:01 am aTyr Pharma confirms that its product candidate Resolaris was granted Orphan Drug Designation by the FDA for the treatment of limb girdle muscular dystrophy patients Briefing.com08:01am EST
aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris™ PR Newswire08:00am EST
Is Illumina On The Verge of a Breakout? at TheStreet06:00am EST
Monday February 27, 2017
[$$] Medical Megadeals Dominate Deal Flow at The Wall Street Journal08:38pm EST
The Hot Stock: Illumina Jumps 4.3% at Barrons.com05:08pm EST
Sunday February 26, 2017
Two Mass. companies involved in some of the biggest tech M&A deals of 2016 at American City Business Journals09:25pm EST
Friday February 24, 2017
4 Stocks You Can Buy and Hold Forever at Motley Fool10:00am EST
Patent Damages In The Global Supply Chain at Forbes09:11am EST
Wednesday February 22, 2017
Thermo Fisher unit prevails in Supreme Court patent case at American City Business Journals01:10pm EST
High court ruling limits international reach of patent laws AP12:49pm EST
Thermo Fisher Comes Out on Top in Promega Patent Case at TheStreet10:25am EST
Thermo Fisher did not infringe genetic-testing patent, U.S. top court says Reuters10:13am EST
Thermo Fisher Backed by Supreme Court in Promega Patent Case Bloomberg10:11am EST
Patent Royalties Curbed as Supreme Court Backs Thermo Fisher at Bloomberg10:11am EST
Tuesday February 21, 2017
ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online01:21pm EST
Baron Opportunity Fund Comments on Illumina Gurufocus11:57am EST
Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference Business Wire06:30am EST
Monday February 20, 2017
Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina Business Wire09:00am EST
Saturday February 18, 2017
Why Illumina Is a Buy at Motley Fool08:45am EST
Friday February 17, 2017
Top Stocks Poised to Bounce Back in 2017 at Motley Fool11:27pm EST
ILLUMINA INC Financials EDGAR Online Financials01:04pm EST
Wednesday February 15, 2017
3 Stocks Set to Profit From the Rise of China at Motley Fool08:20am EST